
News|Articles|October 15, 2025
Sponsored: The Teva Biosimilars Trend Report
Advertisement
The Teva Biosimilars Trend Report: Perspectives from Managed Care, Providers & Employers.
Second edition.
Read the full report below:
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Eric Levine, M.P.H., on Medicaid work requirement exemptions and ADLs
2
New cholesterol guideline expands treatment eligibility to 55% of U.S. adults
3
FDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1
4
Acute pain drug Journavx helps drive Vertex growth in second quarter
5
























